Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: Physicochemical investigations

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 416, Issue 1, 2013, Pages 32-42

  Kumbhar, Dipak D ^a   Pokharkar, Varsha B ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Bicalutamide; Crystalline form I; High pressure homogenization; Nanostructured lipid carrier; Poorly water soluble; Raman analysis

Indexed keywords

CRYSTALLINE MATERIALS; DIFFERENTIAL SCANNING CALORIMETRY; OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

BICALUTAMIDE; CRYSTALLINE FORM; HIGH PRESSURE HOMOGENIZATION; NANOSTRUCTURED LIPID CARRIERS; POORLY WATER-SOLUBLE; RAMAN ANALYSIS;

ENCAPSULATION;

BICALUTAMIDE; GLYCEROL PALMITOSTEARATE; LIPID; NANOMATERIAL; NANOSTRUCTURED LIPID CARRIER; SURFACTANT; TRIACETIN; UNCLASSIFIED DRUG; WATER;

ARTICLE; BIOENGINEERING; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FACTORIAL DESIGN; FICKIAN DIFFUSION; HIGH PRESSURE HOMOGENIZATION; HOMOGENATE; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; NANOENCAPSULATION; PARTICLE SIZE; PHASE TRANSITION; PHYSICAL CHEMISTRY; PRESSURE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPE; SCANNING ELECTRON MICROSCOPY; SUSPENSION; X RAY POWDER DIFFRACTION; ZETA POTENTIAL;

EID: 84877337987     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2012.10.031     Document Type: Article

References (46)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics, CA Cancer J. Clin. 61 (2011) 69-90.
2. A. Heidenreich, G. Aus, M. Bolla, S. Joniau, V.B. Matveev, H.P. Schmid, F. Zattoni, EAU guidelines on prostate cancer, Eur. Urol. 53 (2008) 68-80.
3. A.K. Singh, A. Chaurasiya, G.K. Jain, A. Awasthi, D. Asati, G. Mishra, R.K. Khar, R. Mukherjee, High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats, Talanta 78 (2009) 1310-1314.
4. G.J. Kolvenbag, A. Nash, Bicalutamide dosages used in the treatment of prostate cancer, Prostate 39 (1999) 47-53.
5. F. Ren, Q. Jing, Y. Tang, Y. Shen, J. Chen, F. Gao, J. Cui, Characteristics of bicalutamide solid dispersions and improvement of the dissolution, Drug Dev. Ind. Pharm. 32 (2006) 967-972.
6. M.V. Srikanth, G.V. Murali Mohan Babu, N.S. Rao, S.A. Sunil, S. Balaji, K.V. Ramanamurthy, Dissolution rate enhancement of poorly soluble bicalutamide using β-cyclodextrin inclusion complexation, Int. J. Pharm. Pharm. Sci. 2 (2010) 191-198.
7. C. Li, C. Li, Y. Le, J.F. Chen, Formation of bicalutamide nanodispersion for dissolution rate enhancement, Int. J. Pharm. 404 (2011) 257-263.
8. S.S. Rane, B.D. Anderson, What determines drug solubility in lipid vehicles: is it predictable? Adv. Drug Deliv. Rev. 60 (2008) 638-656.
9. C.J.H. Porter, C.W. Pouton, J.F. Cuine, W.N. Charman, Enhancing intestinal drug solubilization using lipid-based delivery systems, Adv. Drug Deliv. Rev. 60 (2008) 673-691.
10. Y. Luo, D. Chen, L. Ren, X. Zhao, J. Qin, Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability, J. Control. Release 114 (2006) 53-59.
11. A.C. Silva, E. Gonzalez-Mira, M.L. García, M.A. Egea, J. Fonseca, R. Silva, D. Santos, E.B. Souto, D. Ferreira, Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high-pressure homogenization versus ultrasound, Colloids Surf. B 86 (2011) 158-165.
12. R.H. Muller, S. Runge, V. Ravelli, W. Mehnert, A.F. Thunemann, E.B. Souto, Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystals, Int. J. Pharm. 317 (2006) 82-89.
13. H. Li, X. Zhao, Y. Ma, G. Zhai, L. Li, H. Lou, Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles, J. Control. Release 133 (2009) 238-244.
14. S. Doktorovova, E.B. Souto, Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review, Expert Opin. Drug Deliv. 6 (2009) 165-176.
15. V. Jenning, A.F. Thunemann, S.H. Gohla, Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids, Int. J. Pharm. 199 (2000) 167-177.
16. E.B. Souto, S.A. Wissing, C.M. Barbosa, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery, Int. J. Pharm. 278 (2004) 71-77.
17. D.R. Vega, G. Polla, A. Martinez, E. Mendioroz, M. Reinoso, Conformational polymorphism in bicalutamide, Int. J. Pharm. 328 (2007) 112-118.
18. S.R. Vippagunta, H.G. Brittain, Crystalline solids, Adv. Drug Deliv. Rev. 48 (2001) 3-26.
19. I. Kanfer, Report on the international workshop on the biopharmaceutics classification system (BCS): scientific and regulatory aspects in practice, J. Pharm. Pharm. Sci. 5 (2000) 1-4.
20. G.P. Andrews, O.A. Abudiak, D.S. Jones, Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions, J. Pharm. Sci. 99 (2010) 1322-1335.
21. M. Joshi, V. Patravale, Nanostructured lipid carrier (NLC) based gel of celecoxib, Int. J. Pharm. 346 (2008) 124-132.
22. H. Shen, M. Zhong, Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin, J. Pharm. Pharmacol. 58 (2006) 1183-1191.
23. V. Jenning, A. Lippacher, S.H. Gohla, Medium scale production of solid lipid nanoparticles (SLN) by high-pressure homogenization, J. Microencapsul. 19 (2002) 1-10.
24. R.H. Muller, K. Mader, S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art, Eur. J. Pharm. Biopharm. 50 (2000) 161-177.
25. M.N.V. Padamwar, B. Pokharkar, Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability, Int. J. Pharm. 320 (2006) 37-44.
26. D.W. Fry, J.C. White, I.D. Goldman, Rapid separation of low molecular weight solutes from liposome without dilution, Anal. Biochem. 90 (1978) 809-815.
27. F. Han, S. Li, R. Yin, H. Liu, L. Xu, Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers, Colloids Surf. A: Physicochem. Eng. Aspects 315 (2008) 210-216.
28. R.H. Muller, C.M. Keck, Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles, J. Biotechnol. 113 (2004) 151-170.
29. K. Kostarelos, P.F. Luckham, Th.F. Tadros, Effect of the addition of block copolymers on the formation and stability of vesicles (liposomes) prepared using soybean lecithin, Progr. Colloid Polym. Sci. 98 (1995) 69-74.
30. M.A. Schubert, C.C. Muller-Goymann, Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters, Eur. J. Pharm. Biopharm. 55 (2003) 125-131.
31. P. Walstra, Emulsion stability, in: P. Becher (Ed.), Encyclopedia of Emulsion Technology, Marcel Dekker, New York, 1996, pp. 1-62.
32. M.L. Adams, A. Lavasanifar, G.S. Kwon, Amphiphilic block copolymers for drug delivery, J. Pharm. Sci. 92 (2003) 1343-1355.
33. ® as lipophilic glycerides used for the preparation of controlled-release matrix pellets, Int. J. Pharm. 260 (2003) 47-57.
34. W. Zhao, Y. Su, C. Li, Q. Shi, X. Ning, Z. Jiang, Fabrication of antifouling polyethersulfone ultrafiltration membranes using Pluronic F-127 as both surface modifier and pore-forming agent, J. Membr. Sci. 318 (2008) 405-412.
35. W. Abdelwahed, G. Degobert, S. Stainmesse, H. Fessi, Freeze-drying of nanoparticles: formulation, process, and storage considerations, Adv. Drug Deliv. Rev. 58 (2006) 1688-1713.
36. Z. Nemet, J. Sztatisz, A. Demeter, Polymorph transitions of bicalutamide: a remarkable example of mechanical activation, J. Pharm. Sci. 97 (2008) 3222-3232.
37. D.Z. Hou, C.S. Xie, K.J. Huang, C.H. Zhu, The production and characteristics of solid lipid nanoparticles (SLNs), Biomaterials 24 (2003) 1781-1785.
38. O.A. Abu-diak, D.S. Jones, G.P. Andrews, Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterization of microstructural properties using thermal, spectroscopic and drug release methods, J. Pharm. Sci. 101 (2012) 200-213.
39. ® on the properties of lipid controlled release microparticles, J. Control. Release 100 (2004) 233-246.
40. D. Tromans, J.A. Meech, Enhanced dissolution of minerals: stored energy, amorphism, and mechanical activation, Miner. Eng. 14 (2001) 1359-1377.
41. R.N. Rao, A.N. Raju, R. Narsimha, Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study, J. Pharmaceut. Biomed. Anal. 46 (2008) 505-519.
42. V. Jenning, K. Mader, S.H. Gohla, Solid lipid nanoparticles (SLNTM) based on binary mixtures of liquid and solid lipids: a 1H NMR study, Int. J. Pharm. 205 (2000) 15-21.
43. N. Yuksel, M. Baykara, H. Shirinzade, S. Suzen, Investigation of triacetin effect on indomethacin release from poly (methyl methacrylate) microspheres: evaluation of interactions using FTIR and NMR spectroscopies, Int. J. Pharm. 404 (2011) 102-109.
44. ® ATO 5, Int. J. Pharm. 309 (2006) 6-15.
45. A.J. Fillery-Travis, L.H. Foster, M.M. Robins, Stability of emulsions stabilized by two physiological surfactants: l-alpha-phosphatidylcholine and sodium taurocholate, Biophys. Chem. 54 (1995) 253-260.
46. C. Jacobs, R.H. Muller, Production and characterization of a budesonide nanosuspension for pulmonary administration, Pharm. Res. 19 (2002) 189-194.